Financhill
Back

Cytokinetics Stock Predictions

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 9.7% based on the past 21 years of stock performance.
  • Cytokinetics has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $31.00. The Score for CYTK is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 9.7% based on the past 21 years of stock performance.

Cytokinetics Stock Rating

Sell
17
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • The current trend is relatively stagnant and CYTK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
61.40
52-Week Low:
29.31

Prediction Charts

Market Cap:
3.7B
Price in USD:
31.00
Volume:
2.1M
Beta:
1.45

Technical Analysis

SMA50:
39.27
SMA100:
43.14
SMA200:
48.55
52-Wk Change:
-48.26%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 31.00 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 40.72 41.29 41.49 40.46
Apr-30 40.90 42.84 43.51 40.53
May-1 43.02 42.92 43.43 42.00
May-2 37.68 37.35 37.96 34.88
May-5 37.35 36.67 37.40 35.58
May-6 35.85 33.97 36.29 33.97
May-7 35.34 33.04 35.36 32.30
May-8 32.76 32.48 32.98 31.67
May-9 32.35 31.70 33.16 31.69
May-12 31.72 32.13 33.37 31.71
May-13 32.35 30.61 32.95 30.46
May-14 30.50 30.00 31.01 29.93
May-15 30.04 29.84 30.05 29.31
May-16 29.93 31.00 31.54 29.75

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.66 per share, a decrease this year of $0.58 per share, and an increase next year of $0.58 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.